| scholarly article | Q13442814 |
| P50 | author | Niels Høiby | Q12328808 |
| Kaj-Åge Henneberg | Q59680311 | ||
| Thomas Sams | Q40066067 | ||
| Peter Østrup Jensen | Q42574299 | ||
| Mette Kolpen | Q47503370 | ||
| P2093 | author name string | Peter Alexander Vistar Gade | |
| Terkel Bo Olsen | |||
| P2860 | cites work | Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. | Q50452988 |
| A mutation in CFTR produces different phenotypes depending on chromosomal background | Q71604867 | ||
| Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen | Q22122393 | ||
| Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients | Q24551181 | ||
| Cystic fibrosis | Q24680357 | ||
| Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa | Q28267441 | ||
| Pseudomonas aeruginosa biofilms in cystic fibrosis | Q28299966 | ||
| Distinguishing Antimicrobial Models with Different Resistance Mechanisms via Population Pharmacodynamic Modeling | Q28550711 | ||
| Lung infections associated with cystic fibrosis | Q30080000 | ||
| Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection | Q30742543 | ||
| Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients | Q30842136 | ||
| Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum | Q30868724 | ||
| Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment | Q31037210 | ||
| Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms | Q33759060 | ||
| Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections | Q33786154 | ||
| Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa | Q33876563 | ||
| Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin | Q34720396 | ||
| Theoretical aspects of antibiotic diffusion into microbial biofilms | Q35128954 | ||
| New concepts of the pathogenesis of cystic fibrosis lung disease | Q35635720 | ||
| Biofilm accumulation model that predicts antibiotic resistance of Pseudomonas aeruginosa biofilms | Q35820523 | ||
| Antibiotic efficacy is linked to bacterial cellular respiration. | Q35845962 | ||
| Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm Model | Q35996038 | ||
| Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation | Q36002677 | ||
| Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies | Q36039472 | ||
| Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response. | Q36346231 | ||
| The in vivo biofilm | Q38119280 | ||
| Unraveling the physiological complexities of antibiotic lethality. | Q38253949 | ||
| Reaction-diffusion theory explains hypoxia and heterogeneous growth within microbial biofilms associated with chronic infections | Q38673052 | ||
| Biofilms and host response - helpful or harmful | Q39240791 | ||
| Hyperbaric oxygen sensitizes anoxic Pseudomonas aeruginosa biofilm to ciprofloxacin | Q40065973 | ||
| Modeling antibiotic tolerance in biofilms by accounting for nutrient limitation | Q40410435 | ||
| Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment | Q40533096 | ||
| Enzymatic characterization and in vivo function of five terminal oxidases in Pseudomonas aeruginosa | Q41906936 | ||
| Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. | Q42563377 | ||
| Regulation and Function of Versatile Aerobic and Anaerobic Respiratory Metabolism in Pseudomonas aeruginosa | Q42750768 | ||
| Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis | Q43257270 | ||
| Modelling time-kill studies to discern the pharmacodynamics of meropenem | Q46384221 | ||
| Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen | Q46921876 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| biofilm | Q467410 | ||
| P304 | page(s) | e0198909 | |
| P577 | publication date | 2018-06-14 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms | |
| P478 | volume | 13 |
| Q64063192 | Antimicrobial Blue Light Inactivation of Polymicrobial Biofilms |
| Q91741389 | Recent Advances in Non-Conventional Antimicrobial Approaches for Chronic Wound Biofilms: Have We Found the 'Chink in the Armor'? |
| Q64068057 | Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents—How P. aeruginosa Can Escape Antibiotics |
Search more.